首页|雄激素受体、Ki-67在三阴性乳腺癌中的表达以及与预后的关系

雄激素受体、Ki-67在三阴性乳腺癌中的表达以及与预后的关系

扫码查看
目的 探讨雄激素受体和Ki-67在三阴性乳腺癌(TNBC)中的表达,并研究它们与患者预后的关系.方法 选择了朝阳市中心医院2015年1月~2020年5月期间治疗的TNBC女性患者88例作为观察组,同时纳入了非三阴性乳腺癌(NTNBC)女性患者89例作为对照组.我们检测了AR和Ki-67的表达情况,并观察它们在TNBC中的表达差异,同时分析了它们与患者预后的关系.结果 AR在观察组的表达率低于对照组(P<0.05),而Ki-67在观察组中的表达率高于对照组(P<0.05).AR和Ki-67的表达均与肿瘤直径以及淋巴结转移个数有关(P<0.05).COX回归分析显示,病理分级、淋巴结转移个数、AR和Ki-67表达情况是影响TNBC预后的独立影响因素(P<0.05).结论 AR和Ki-67与TNBC的预后密切相关,AR阳性表达和Ki-67低表达的患者提示预后较好,生存时间更长.
Expression of Androgen Receptor and Ki-67 in Triple-negative Breast Cancer and Its Association with Prognosis
Objective To investigate the expression of androgen receptor(AR)and Ki-67 in triple-negative breast cancer,and to study their relationship with patients'prognosis.Methods Eighty-eight female TNBC patients treated at Chaoyang Central Hospital from January 2015 to May 2020 were included in the observation group,while 89 female NTNBC patients were included as a control group.We examined the expression of AR and Ki-67 and observed the differences in their expression in triple-negative breast cancer,and analysed their relationship with patients'prognosis.Results The expression rate of AR in the observation group was lower than that in the control group(P<0.05),while the expression rate of Ki-67 in the observation group was higher than that in the control group(P<0.05).The expression of AR and Ki-67 is related to tumor diameter and the number of lymph node metastases(P<0.05).COX regression analysis showed that pathological grade,number of lymph node metastases,AR and Ki-67 expression were independent influences on the prognosis of triple-negative breast cancer(P<0.05).Conclusion AR and Ki-67 were closely related to the prognosis of triple-negative breast cancer.Patients with positive AR expression and low Ki-67 expression suggested a better prognosis and longer survival time.

triple negative breast cancerandrogen receptorKi-67prognosis

王维斯、国士刚、李国明、付新澳、李居尚、范宗奇

展开 >

承德医学院研究生学院,河北承德 067000

朝阳市中心医院

中国医科大学朝阳市中心医院

三阴性乳腺癌 AR Ki-67 预后

2024

承德医学院学报
承德医学院

承德医学院学报

影响因子:0.451
ISSN:1004-6879
年,卷(期):2024.41(1)
  • 2